Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Theralase Hiring New IR Coordinator

<< Previous

Bullboard Posts

Next >>

Comment by skys1on May 09, 2022 3:34pm

248 Views

Post# 34668127

RE:RE:RE:RE:RE:RE:RE:RE:RE:Theralase Hiring New IR Coordinator

Yes, there is no signed deal in place, however I believe Li Ka Shing is hoping in that direction with the gift of the new bio lab, plus they have already referred to TLT as, "partner". When TLT gets the needed approvals to commercialize their ACT which should be close to year end, they sign a deal and Li Ka Shing puts their worldwide pharma wheels in motion. This also explains why TLT no longer seems to be concerned about future cash needs as they have enough cash to get to year end. This is all in just my opinion of course.

<< Previous

Bullboard Posts

Next >>

Rich TV Live's Stocks to Watch this week (Nov. 22, 2024)